Summary

Eligibility
for people ages 65-99 (full criteria)
Location
at San Francisco, California
Dates
study started
completion around
Principal Investigator
by Adam Staffaroni, PhDOdmara Barreto Chang, MD, PhD

Description

Summary

This is a pilot study to evaluate the use of remote cognitive testing to identify patients who may have cognitive vulnerability and may benefit from cognitive care pathways. Participants in this study are asked to complete a smartphone battery of thinking, memory, speech, and motor function tests on their smartphone.

Official Title

Remote Evaluation of Cognitive Function for Older Adults Undergoing Surgery

Details

This study is evaluating cognitive function in older adults that are undergoing surgery using remote assessments. Participants complete a battery of neuropsychological assessments prior to their surgery date. The battery includes smartphone adaptions of tests of thinking, memory, speech, and movement. The participant has a one-hour remote visit, where the investigators will conduct a Montreal Cognitive Assessment (MoCA) and have the participant complete the smartphone assessments. After their surgery, participants are evaluated on the delirium rating scale.

Keywords

Mild Cognitive Impairment, Delirium, Remote Cognitive Assessment, Cognitive Dysfunction

Eligibility

You can join if…

Open to people ages 65-99

  • Spine surgery with a duration greater than or equal to three hours
  • Can speak, write, and understand English
  • Ability to participate in remote visit

You CAN'T join if...

  • Participating in other cognitive studies
  • Having more than one surgery (planned multiday surgery)
  • Emergency surgery

Location

  • UCSF accepting new patients
    San Francisco California 94158 United States

Lead Scientists at UCSF

  • Adam Staffaroni, PhD
    Dr. Staffaroni is a clinical neuropsychologist and Associate Professor at the UCSF Memory and Aging Center. His research focuses on improving early detection, prognosis, and monitoring of neurodegenerative diseases through a combination of clinical tests, neuroimaging, and blood-based biomarkers.
  • Odmara Barreto Chang, MD, PhD

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT05566275
Study Type
Observational
Participants
Expecting 30 study participants
Last Updated